<DOC>
	<DOCNO>NCT00286169</DOCNO>
	<brief_summary>The purpose study compare efficacy toxicity amrubicin carboplatin plus etoposide elderly patient extensive-disease small-cell lung cancer .</brief_summary>
	<brief_title>Amrubicin Study Elderly Patients With Extensive-disease Small-cell Lung Cancer ( ED-SCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Amrubicin</mesh_term>
	<criteria>Extensivedisease smallcell lung cancer Aged 70 year old Performance status 02 No prior chemotherapy Prior therapy primary lesion Pneumonitis and/or pulmonary fibrosis Active concomitant malignancy</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Extensive-disease small-cell lung cancer ( ED-SCLC )</keyword>
</DOC>